ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for ACRV

Stock NameAcrivon Therapeutics, Inc. Common Stock
TickerACRV(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS0048901096

Show aggregate ACRV holdings

News associated with ACRV

Brokerages Set Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Target Price at $17.57
Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) have received an average recommendation of “Buy” from the ten research firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has given a strong buy recommendation to […] - 2025-09-05 02:52:51
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Given Consensus Recommendation of “Buy” by Analysts
Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) have been given an average recommendation of “Buy” by the ten analysts that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation […] - 2025-07-14 05:38:48
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives $17.71 Consensus Price Target from Brokerages
Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) have earned an average recommendation of “Buy” from the ten ratings firms that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and one has issued a strong buy […] - 2025-06-24 03:10:51
Acrivon Therapeutics (NASDAQ:ACRV) Now Covered by Analysts at Piper Sandler
Analysts at Piper Sandler assumed coverage on shares of Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) in a research report issued on Monday, MarketBeat reports. The firm set an “overweight” rating and a $6.00 price target on the stock. Piper Sandler’s target price would indicate a potential upside of 352.83% from the company’s current price. […] - 2025-05-07 03:06:49
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Given Consensus Rating of “Buy” by Brokerages
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) has received an average rating of “Buy” from the seven analysts that are currently covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy rating. The average 1 year target price among brokerages that have issued a report on the stock […] - 2025-05-05 05:00:51
Pre-Market Most Active for Apr 25, 2025 : TSLL, SQQQ, ACRV, TQQQ, INTC, NVDA, BBAI, NIO, WOLF, QBTS, JPM, BEKE
The NASDAQ 100 Pre-Market Indicator is down -26.59 to 19,187.81. The total Pre-Market volume is currently 153,863,180 shares traded.The following are the most active stocks for the pre-market session: Direxion Daily TSLA Bull 2X Shares (TSLL) is +0.09 at $8.83, with 18,551,618 s - 2025-04-25 09:28:55
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Sees Significant Growth in Short Interest
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 887,100 shares, a growth of 21.4% from the March 15th total of 730,600 shares. Based on an average trading volume of 120,400 shares, the days-to-cover ratio […] - 2025-04-21 02:52:45
Trexquant Investment LP Has $102,000 Holdings in Acrivon Therapeutics, Inc. (NASDAQ:ACRV)
Trexquant Investment LP trimmed its position in Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Free Report) by 44.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,871 shares of the company’s stock after selling 13,512 shares during the quarter. Trexquant Investment LP’s holdings […] - 2025-04-15 04:39:27
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Given Average Rating of “Buy” by Analysts
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) has been given an average recommendation of “Buy” by the eight analysts that are presently covering the stock, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12 month price objective among analysts that have covered the stock in the […] - 2025-02-19 07:05:06
China Universal Asset Management Co. Ltd. Takes Position in Acrivon Therapeutics, Inc. (NASDAQ:ACRV)
China Universal Asset Management Co. Ltd. bought a new stake in Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 6,602 shares of the company’s stock, valued at approximately $40,000. A number of […] - 2025-02-05 06:46:55

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) ACRV holdings

DateNumber of ACRV Shares HeldBase Market Value of ACRV SharesLocal Market Value of ACRV SharesChange in ACRV Shares HeldChange in ACRV Base ValueCurrent Price per ACRV Share HeldPrevious Price per ACRV Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ACRV by Blackrock for IE00BYXG2H39

Show aggregate share trades of ACRV

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-06BUY1531.9101.985 1.978USD 303 2.67
2025-10-03BUY3571.9101.980 1.973USD 704 2.67
2025-10-02BUY511.8601.900 1.896USD 97 2.68
2025-09-30BUY1021.8101.830 1.828USD 186 2.69
2025-09-26BUY1021.6601.680 1.678USD 171 2.70
2025-09-25BUY1021.5401.620 1.612USD 164 2.70
2025-09-24BUY11.5601.650 1.641USD 2 2.71
2025-09-18BUY501.6701.690 1.688USD 84 2.72
2025-09-17BUY1531.5601.660 1.650USD 252 2.72
2025-09-11SELL-511.5501.660 1.649USD -84 2.75 Profit of 56 on sale
2025-09-10BUY1021.6301.720 1.711USD 175 2.76
2025-09-05SELL-511.3301.370 1.366USD -70 2.78 Profit of 72 on sale
2025-08-29SELL-1531.3401.370 1.367USD -209 2.81 Profit of 221 on sale
2025-08-27BUY1021.3601.381 1.379USD 141 2.83
2025-08-26SELL-511.3301.350 1.348USD -69 2.84 Profit of 76 on sale
2025-08-25BUY511.3301.395 1.388USD 71 2.85
2025-08-20SELL-2041.3001.350 1.345USD -274 2.87 Profit of 311 on sale
2025-08-18BUY1021.3901.435 1.430USD 146 2.89
2025-08-08SELL-1021.2401.285 1.280USD -131 2.94 Profit of 169 on sale
2025-08-05BUY511.3001.350 1.345USD 69 2.98
2025-08-01SELL-1521.2601.288 1.285USD -195 3.00 Profit of 260 on sale
2025-07-30BUY2041.3201.440 1.428USD 291 3.02
2025-07-17SELL-1021.3201.400 1.392USD -142 3.13 Profit of 177 on sale
2025-07-11SELL-4081.3201.345 1.343USD -548 3.19 Profit of 752 on sale
2025-07-07BUY1531.2501.310 1.304USD 200 3.25
2025-07-02BUY2,7501.2901.390 1.380USD 3,795 3.29
2025-06-25BUY1001.3301.330 1.330USD 133 3.36
2025-06-11BUY1001.2701.340 1.333USD 133 3.55
2025-06-10BUY1001.2801.330 1.325USD 133 3.58
2025-06-04SELL-501.2301.240 1.239USD -62 3.66 Profit of 121 on sale
2025-04-23BUY502.0002.120 2.108USD 105 4.61
2025-04-10SELL-4081.5301.630 1.620USD -661 5.00 Profit of 1,378 on sale
2025-04-08SELL-511.3601.699 1.665USD -85 5.11 Profit of 176 on sale
2025-04-07SELL-511.3901.640 1.615USD -82 5.17 Profit of 181 on sale
2025-04-04SELL-2551.5101.675 1.658USD -423 5.23 Profit of 910 on sale
2025-04-01BUY2041.6801.990 1.959USD 400 5.34
2025-03-31SELL-1532.0302.300 2.273USD -348 5.40 Profit of 478 on sale
2025-03-14SELL-8165.4405.460 5.458USD -4,454 5.58 Profit of 102 on sale
2025-03-07SELL-1025.5405.580 5.576USD -569 5.61 Profit of 4 on sale
2025-03-04SELL-515.3605.550 5.531USD -282 5.62 Profit of 5 on sale
2025-02-25BUY1025.5305.680 5.665USD 578 5.66
2025-02-19SELL-515.3105.360 5.355USD -273 5.68 Profit of 17 on sale
2025-02-13BUY1535.3605.365 5.364USD 821 5.73
2025-02-12BUY515.1605.160 5.160USD 263 5.75
2025-02-11BUY2044.9105.490 5.432USD 1,108 5.78
2025-01-17BUY2045.7805.880 5.870USD 1,197 5.69
2025-01-16BUY2045.5505.660 5.649USD 1,152 5.71
2025-01-10SELL-1025.4706.000 5.947USD -607 5.96 Profit of 2 on sale
2025-01-08SELL-2046.1006.340 6.316USD -1,288 5.69 Loss of -128 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ACRV

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1952,594679153,38334.3%
2025-09-1859,398234178,01433.4%
2025-09-17251,611935540,53446.5%
2025-09-16118,270737389,08930.4%
2025-09-15195,2679,300408,02347.9%
2025-09-12240,541740410,37958.6%
2025-09-11246,469320554,58944.4%
2025-09-10179,15022,093423,53342.3%
2025-09-09684,616112,6271,576,36543.4%
2025-09-0814,887,970151,90926,628,33255.9%
2025-09-0534,918083,66741.7%
2025-09-0441,529098,74642.1%
2025-09-039,928030,93632.1%
2025-09-0213,843029,81246.4%
2025-08-298,581032,10126.7%
2025-08-2816,255057,03928.5%
2025-08-2745,84669397,28347.1%
2025-08-2629,247085,94234.0%
2025-08-2533,419074,99844.6%
2025-08-2240,3040106,35337.9%
2025-08-2124,752064,89138.1%
2025-08-2029,946092,77432.3%
2025-08-19113,735751282,48640.3%
2025-08-1843,154100128,18333.7%
2025-08-1533,9750130,02226.1%
2025-08-1481,9521,000190,64343.0%
2025-08-1361,950300143,73743.1%
2025-08-1246,232096,69147.8%
2025-08-1120,687073,60428.1%
2025-08-0829,848064,20246.5%
2025-08-0729,711077,08938.5%
2025-08-0636,608076,49047.9%
2025-08-0528,9116,230120,08124.1%
2025-08-0442,963074,72457.5%
2025-08-0129,30510077,59937.8%
2025-07-3144,7720119,98837.3%
2025-07-3076,6920211,46836.3%
2025-07-29151,142100244,87261.7%
2025-07-2885,6516,050250,35734.2%
2025-07-2589,6525,707220,22240.7%
2025-07-2446,954100135,42034.7%
2025-07-23125,7610368,30734.1%
2025-07-2227,3690137,63619.9%
2025-07-2139,9590171,48923.3%
2025-07-1862,4232,600210,81429.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy